Search Results

There are 15483 results for: content related to: Clinical reactivation during lamivudine treatment correlates with mutations in the precore/core promoter and polymerase regions of hepatitis B virus in patients with anti-hepatitis B e-positive chronic hepatitis

  1. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  2. You have free access to this content
    AASLD Abstracts 895–1142

    Hepatology

    Volume 48, Issue S1, October 2008, Pages: 707A–816A,

    Version of Record online : 24 SEP 2008, DOI: 10.1002/hep.22644

  3. Complete hepatitis B virus genome analysis in chronically infected children before and during lamivudine treatment

    Journal of Medical Virology

    Volume 77, Issue 2, October 2005, Pages: 194–202, Isabel Conzelmann, Philip Wintermeyer, Stefan Wirth, Robert Radke and Patrick Gerner

    Version of Record online : 24 AUG 2005, DOI: 10.1002/jmv.20436

  4. You have free access to this content
    Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure

    Journal of Gastroenterology and Hepatology

    Volume 25, Issue 3, March 2010, Pages: 583–590, Li-Jie Sun, Jian-Wu Yu, Yong-Hua Zhao, Peng Kang and Shu-Chen Li

    Version of Record online : 24 NOV 2009, DOI: 10.1111/j.1440-1746.2009.06089.x

  5. Efficacy of switching to telbivudine in chronic hepatitis B patients treated previously with lamivudine

    Liver International

    Volume 31, Issue 5, May 2011, Pages: 667–675, Rifaat Safadi, Qing Xie, Yagang Chen, You-Kuan Yin, Lai Wei, Seong Gyu Hwang, Eli Zuckerman, Ji-Dong Jia and Patricia Lopez

    Version of Record online : 29 OCT 2010, DOI: 10.1111/j.1478-3231.2010.02360.x

  6. Abstract Index

    Journal of Gastroenterology and Hepatology

    Volume 19, Issue s7, December 2004, Pages: A676–A868,

    Version of Record online : 3 DEC 2004, DOI: 10.1111/j.1440-1746.2004.03735.x

  7. Should lamivudine monotherapy be stopped or continued in patients infected with hepatitis B with favorable responses after more than 5 years of treatment?

    Journal of Medical Virology

    Volume 85, Issue 1, January 2013, Pages: 34–42, Jung Hyun Kwon, Jeong Won Jang, Jong Young Choi, Chung-Hwa Park, Sun Hong Yoo, Si Hyun Bae and Seung Kew Yoon

    Version of Record online : 14 NOV 2012, DOI: 10.1002/jmv.23421

  8. Management of viral hepatitis B

    Journal of Gastroenterology and Hepatology

    Volume 17, Issue s1, February 2002, Pages: S125–S145, CHUTIMA PRAMOOLSINSUP

    Version of Record online : 8 MAY 2002, DOI: 10.1046/j.1440-1746.17.s1.3.x

  9. Lamivudine salts with improved solubilities

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 6, June 2012, Pages: 2143–2154, Felipe T. Martins, Rudy Bonfilio, Magali B. De Araújo and Javier Ellena

    Version of Record online : 14 MAR 2012, DOI: 10.1002/jps.23117

  10. Management of chronic hepatitis B virus infection: a new era of disease control

    Internal Medicine Journal

    Volume 36, Issue 2, February 2006, Pages: 100–113, G. C. Farrell and N. C. Teoh

    Version of Record online : 10 FEB 2006, DOI: 10.1111/j.1445-5994.2006.01027.x

  11. Viral Hepatitis

    Textbook of Hepatology: From Basic Science to Clinical Practice, Third Edition

    Mario Rizzetto, Fabien Zoulim, Pages: 819–956, 2008

    Published Online : 15 APR 2008, DOI: 10.1002/9780470691861.ch9a

  12. Lamivudine treatment of chronic hepatitis B

    Reviews in Medical Virology

    Volume 8, Issue 3, July/September 1998, Pages: 153–159, Geoffrey Dusheiko

    Version of Record online : 4 MAY 1999, DOI: 10.1002/(SICI)1099-1654(199807/09)8:3<153::AID-RMV228>3.0.CO;2-Y

  13. You have free access to this content
    Combination of HBIG and lamivudine-resistant mutations: A formula for trouble?

    Liver Transplantation

    Volume 8, Issue 11, November 2002, Pages: 1082–1084, Robert J. Fontana and Anna S.F. Lok

    Version of Record online : 30 DEC 2003, DOI: 10.1053/jlts.2002.36238

  14. You have free access to this content
    Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B: Antiviral and immunological activity

    Hepatology

    Volume 42, Issue 5, November 2005, Pages: 1028–1036, Eirini I. Rigopoulou, Deepak Suri, Shilpa Chokshi, Ivana Mullerova, Steven Rice, Richard S. Tedder, Roger Williams and Nikolai V. Naoumov

    Version of Record online : 25 OCT 2005, DOI: 10.1002/hep.20888

  15. Hepatitis B virus polymerase variants associated with entecavir drug resistance in treatment-naive patients

    Journal of Viral Hepatitis

    Volume 14, Issue 12, December 2007, Pages: 835–840, R. Jardi, F. Rodriguez-Frias, M. Schaper, G. Ruiz, I. Elefsiniotis, R. Esteban and M. Buti

    Version of Record online : 24 SEP 2007, DOI: 10.1111/j.1365-2893.2007.00877.x

  16. You have free access to this content
    A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial

    Hepatology

    Volume 47, Issue 3, March 2008, Pages: 844–853, Chiun Hsu, Chao A. Hsiung, Ih-Jen Su, Wei-Shou Hwang, Ming-Chung Wang, Sheng-Fung Lin, Tseng-Hsi Lin, Hui-Hua Hsiao, Ji-Hsiung Young, Ming-Chih Chang, Yu-Min Liao, Chi-Cheng Li, Hung-Bo Wu, Hwei-Fang Tien, Tsu-Yi Chao, Tsang-Wu Liu, Ann-Lii Cheng and Pei-Jer Chen

    Version of Record online : 27 DEC 2007, DOI: 10.1002/hep.22106

  17. You have free access to this content
    Efficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis BB

    Hepatology

    Volume 29, Issue 3, March 1999, Pages: 889–896, Nicolaos C. Tassopoulos, Riccardo Volpes, Giuseppe Pastore, Jenny Heathcote, Maria Buti, Robert D. Goldin, Sasha Hawley, Judy Barber, Lynn Condreay and D. Fraser Gray

    Version of Record online : 30 DEC 2003, DOI: 10.1002/hep.510290321

  18. Correlation of YMDD mutation and breakthrough hepatitis with hepatitis B virus DNA and serum ALT during lamivudine treatment

    Hepatology Research

    Volume 40, Issue 2, February 2010, Pages: 125–134, Mariko Kobayashi, Fumitaka Suzuki, Norio Akuta, Hiromi Yatsuji, Tetsuya Hosaka, Hitomi Sezaki, Masahiro Kobayashi, Yusuke Kawamura, Yoshiyuki Suzuki, Yasuji Arase, Kenji Ikeda, Rie Mineta, Satomi Iwasaki, Sachiyo Watahiki and Hiromitsu Kumada

    Version of Record online : 25 SEP 2009, DOI: 10.1111/j.1872-034X.2009.00565.x

  19. You have free access to this content
    Chronic hepatitis B

    Hepatology

    Volume 45, Issue 2, February 2007, Pages: 507–539, Anna S. F. Lok and Brian J. McMahon

    Version of Record online : 26 JAN 2007, DOI: 10.1002/hep.21513

  20. Stopping lamivudine therapy after biochemical breakthrough may be a feasible option in selected HBeAg-positive patients

    Journal of Medical Virology

    Volume 77, Issue 3, November 2005, Pages: 367–373, Jeong Won Jang, Jong Young Choi, Si Hyun Bae, Seung Kew Yoon, Chang Wook Kim, Soon Woo Nam, Chang Don Lee, Young Sok Lee, Sang Bok Cha and Kyu Won Chung

    Version of Record online : 19 SEP 2005, DOI: 10.1002/jmv.20465